ExomeChip-based rare variant association study in restless legs syndrome

Area of Science:

• Genetics
• Neurology
• Sleep Medicine

Background:

• Restless Legs Syndrome (RLS) is a prevalent sleep disorder, particularly in individuals of European descent.
• Genetic factors significantly influence RLS risk, with common variants extensively studied.
• The role of rare genetic variations in RLS pathogenesis remains largely unexplored at scale.

Purpose of the Study:

• To investigate the contribution of rare and low-frequency exonic variants to Restless Legs Syndrome risk.
• To assess the utility of exome chip genotyping for identifying rare genetic risk factors in RLS.

Main Methods:

• Genotyping of a case-control cohort comprising 9246 individuals using the Illumina ExomeChip.
• Analysis focused on rare and low-frequency exonic variants.
• Standard single variant and gene-level association tests were performed.

Main Results:

• No significant associations were detected between the genotyped rare/low-frequency variants and Restless Legs Syndrome.
• The study's sample size and the limited scope of variants on the ExomeChip may have hindered the detection of true associations.

Conclusions:

• The current study did not identify rare genetic variants contributing to RLS risk, despite a large sample size for exome chip analysis.
• Larger sample sizes or alternative approaches like exome or whole genome sequencing are recommended for future studies aiming to identify rare risk variants for RLS.
• This research highlights the limitations of current exome chip arrays for comprehensively assessing the role of rare genetic variation in complex diseases like RLS.